PATHOLOGIC PHYSIOLOGY OF EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Por S. N. Avdeev
Publicado em 2019-05-01

NEW FIXED COMBINATION OF LONG-ACTING ANTICHOLINERGIC GLYCOPYRRONIUM BROMIDE AND β2-AGONIST OF INDACATEROL: PROSPECTS OF COBD THERAPY

Por S. N. AVDEEV
Publicado em 2016-12-01

Anti-inflammatory therapy in chronic obstructive pulmonary disease: present and future

Por S. N. Avdeev
Publicado em 2013-12-01

Current approaches to management of patients with pulmonary hypertension

Por S. N. Avdeev
Publicado em 2014-12-01

Idiopatic pulmonary fibrosis: A new paradigm

Por S N Avdeev
Publicado em 2017-01-01

Legochnaya gipertenziya pri khronicheskoy obstruktivnoy bolezni legkikh

Por S N Avdeev
Publicado em 2004-03-01

Noninvasive ventilation in hospitalized patients with chronic obstructive pulmonary disease

Por Sergey N. Avdeev
Publicado em 2017-07-01

Glycopyrronium bromide is a new long-acting anticholinergic drug for the treatment of COPD

Por S. N. Avdeev, S. Y. Chikina
Publicado em 2014-12-01

Glycopyrronium bromide: clinical efficacy and safety in patients with COPD (a review of clinical trials)

Por S. Y. Chikina, S. N. Avdeev
Publicado em 2015-12-01

Antifibrotic therapy of idiopathic pulmonary fibrosis: efficiency / safety ratio

Por S. N. Avdeev, N. V. Trushenko
Publicado em 2018-10-01

Riociguat is a novel medication for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

Por N. A. Tsareva, S. N. Avdeev
Publicado em 2016-12-01

Risk stratification methods and their significance in pulmonary arterial hypertension

Por S N Avdeev, N A Tsareva
Publicado em 2019-09-01

Pharmacoeconomic analysis of using biological agents for uncontrolled moderate-to-severe atopic asthma in the Russian Federation

Por S. K. Zyryanov, I. N. Diyakov, S. N. Avdeev
Publicado em 2020-02-01

INFLUENCE OF PULMONARY HYPERTENSION ON CLINICAL COURSE AND PROGNOSIS OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Por S. N. Avdeev, V. V. Gajnitdinova, N. A. Tsareva, Z. М. Merzhoeva
Publicado em 2018-07-01

COVID-19 and chronic obstructive pulmonary disease: what is known about the unknown

Por E. S. Ovsyannikov, S. N. Avdeev, A. V. Budnevskiy, E. S. Drobysheva, A. Ya. Kravchenko
Publicado em 2021-03-01

Eosinophilic inflammation in chronic obstructive pulmonary disease

Por S N Avdeev, N V Trushenko, Z M Merzhoeva, M S Ivanova, E V Kusraeva
Publicado em 2019-10-01

Corrected orthogonal vectorcardiography in pulmonary hypertension diagnostics

Por E. S. Yurasova, T. A. Sakhnova, I. E. Chazova, N. A. Tsareva, S. N. Avdeev, O. Yu. At’kov
Publicado em 2005-12-01

Drug-Induced Lung Disease (Organizing Pneumonia) Associated with Mesalazine

Por E. V. Smirnova, D. A. Strelkova, S. A. Ratchina, S. N. Avdeev, O. V. Aryutina, O. Yu. Karpova
Publicado em 2022-02-01

Clinical, radiologic, and morphological diagnosis of hypersensitivity pneumonitis

Por A. L. Cherniaev, E. V. Kusraeva, M. V. Samsonova, S. N. Avdeev, N. V. Trushenko, E. L. Tumanova
Publicado em 2022-01-01

Clinical and economic analysis of Reslizumab use in the treatment of patients with severe allergic eosinophilic asthma

Por A S Kolbin, S N Avdeev, M V Zhuravleva, Yu M Gomon, Yu E Balykina, N V Matveyev, M A Proskurin, S V Fedosenko
Publicado em 2019-12-01